Fungal allergens induce cathelicidin LL-37 expression in chronic rhinosinusitis patients in a nasal explant model

American Journal of Rhinology

Volumn 21, Issue 3, 2007, Pages 367-372

  Eng, Hooi Ooi ^a   Wormald, Peter John ^a,c   Carney, A Simon ^a   James, Craig Lloyd ^b   Lor, Wai Tan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Adelaide Pathology Partners   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Allergic fungal sinusitis; Antimicrobial peptide; Cathelicidin LL 37; Chronic rhinosinusitis; Innate immunity

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37;

ALTERNARIA; ARTICLE; ASPERGILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOASSAY; IN VITRO STUDY; INNATE IMMUNITY; NASAL BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOSINUSITIS; UPREGULATION;

ALLERGENS; ALTERNARIA; ANTIMICROBIAL CATIONIC PEPTIDES; ASPERGILLUS; BIOPSY; CELLS, CULTURED; FUNGI; HUMANS; LIPOPOLYSACCHARIDES; MULTIGENE FAMILY; PARANASAL SINUSES; RHINITIS; RNA, MESSENGER; SINUSITIS; UP-REGULATION;

EID: 34250857507     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2007.21.3025     Document Type: Article

References (21)

1. Katzenstein AL, Sale SR, and nberger PA. Allergic Aspergillus sinusitis: A newly recognized form of sinusitis. J Allergy Clin Immunol 72:89-93, 1983.
2. Schubert MS, and Goetz DW. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol 102:387-394, 1998.
3. Collins MM, Nair SB, and Wormald PJ. Prevalence of non-invasive fungal sinusitis in South Australia. Am J Rhinol 17:127-132, 2003.
4. Ferguson BJ. Eosinophilic mucin rhinosinusitis: A distinct clinicopathological entity. Laryngoscope 110:799-813, 2000.
5. Collins M, Nair S, Smith W, et al. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope 114:1242-1246, 2004.
6. Mitakakis TZ, Tovey ER, Xuan W, and Marks GB. Personal exposure to allergenic pollen and mould spores in inland New South Wales, Australia. Clin Exp Allergy 30:1733-1739, 2000.
7. Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev 173:27-38, 2000.
8. Sorensen OE, Follin P, Johnsen AH, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951-3959, 2001.
9. Bals R, Wang X, Zasloff M, and Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 95:9541-9546, 1998.
10. Yoshio H, Tollin M, Gudmundsson GH, et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: Implications for newborn innate defense. Pediatr Res 53: 211-216, 2003.
11. Chen PH, and Fang SY. The expression of human antimicrobial peptide LL-37 in the human nasal mucosa. Am J Rhinol 18:381-385, 2004.
12. Benninger MS, Ferguson BJ, Hadley J A, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129:S1-S32, 2003.
13. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-1160, 2002.
14. Livak KJ, and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408, 2001.
15. Islam D, Bandholtz L, Nilsson J, et al. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7:180-185, 2001.
16. Fakhri S, Tulic M, Christodoulopoulos P, et al. Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model. Laryngoscope 114: 887-892, 2004.
17. Wallwork B, Coman W, Feron F, et al. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope 112:1827-1830, 2002.
18. Mitakakis TZ, Barnes C, and Tovey ER. Spore germination increases allergen release from Alternaria. J Allergy Clin Immunol 107:388-390, 2001.
19. Downs SH, Mitakakis TZ, Marks GB, et al. Clinical importance of Alternaria exposure in children. Am J Respir Crit Care Med 164:455-459, 2001.
20. Lackner A, Stammberger H, Buzina W, et al. Fungi: A normal content of human nasal mucus. Am J Rhinol 19:125-129, 2005.
21. Bals R, Weiner DJ, Meegalla RL, and Wilson JM. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest 103: 1113-1117, 1999.